Adoptive immunotherapy of experimental tumors using cytotoxic lymphocytes to carry and deliver toxins.
Adoptive transfer of specifically sensitized lymphoid cells constitutes a potential tool for specific cancer immunotherapy, however, the requirement of syngeneic or autologous specifically reactive cells has limited its use in the treatment of human cancer. In several mouse tumor models, large amoun...
Main Authors: | Zanovello, P, Rosato, A, Bronte, V, Cerundolo, V, Collavo, D |
---|---|
Format: | Journal article |
Language: | English |
Published: |
1991
|
Similar Items
-
Resistance of lymphokine-activated T lymphocytes to cell-mediated cytotoxicity.
by: Zanovello, P, et al.
Published: (1989) -
Generation and enrichment of antigen-specific cytotoxic T lymphocytes for adoptive transfer in tumor immunotherapy.
by: Oelke, M, et al.
Published: (2000) -
Antitumour efficacy of lymphokine-activated killer cells loaded with ricin against experimentally induced lung metastases.
by: Zanovello, P, et al.
Published: (1992) -
Generation and purification of CD8+ melan-A-specific cytotoxic T lymphocytes for adoptive transfer in tumor immunotherapy.
by: Oelke, M, et al.
Published: (2000) -
Reversibility of lymphokine-induced NK-like activity in virus-specific cytotoxic T-lymphocyte clones.
by: Ronchese, F, et al.
Published: (1985)